MED — Medifast Balance Sheet
0.000.00%
Last trade - 00:00
- $353.45m
- $203.41m
- $1.07bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 92.7 | 174 | 110 | 87.7 | 150 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6.61 | 0.584 | 0.945 | 0 | 8.73 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 154 | 234 | 307 | 223 | 224 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 38.8 | 38.1 | 80.6 | 75.6 | 67.1 |
Other Long Term Assets | |||||
Total Assets | 195 | 276 | 398 | 316 | 310 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 79.4 | 111 | 170 | 141 | 92.3 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 89.8 | 119 | 196 | 161 | 108 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 105 | 157 | 202 | 155 | 201 |
Total Liabilities & Shareholders' Equity | 195 | 276 | 398 | 316 | 310 |
Total Common Shares Outstanding |